CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
Companies are making money, the economy is cooling down, and a rate cut or two possible by the fall? It might be time to break out the cautious optimism.
Fed Chair Jerome Powell reported that rates would likely remain elevated due to sticky inflation. Zillow breaks down how this could impact the housing market.
Amanda Chin, SVP of Marketing for the Golden State Warriors, stops by Cheddar to debut Valkyries name and logo and talks why women sports is good for business.
The return of ‘meme stocks’ don’t mean it’s time to panic about the stock market. If you want something to worry about… look no further than inflation.
Andela is revolutionizing global work for a sustainable future. Their impact includes diverse skills, income growth, & successful hiring in untapped locations.
